|
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.(b)(4).A review of the device history record has been completed.No deviations or non-conformances noted.The event of "seroma" is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: fluid, pain, and implant exchange due to concern with the product.Device evaluation: analysis of the returned device identified: analysis of the returned device identified: weight to the spec, yellow particles in the shell and crease fold.Cloudy and voids in the gel observed after autoclave cycle.Base on the device analysis the final assessment is: no issues found related with the manufacturing process.
|